Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Tasigna shows rapid and deep responses in newly diagnosed patients with a form of chronic myeloid leukemia
Novartis, 06/08/09
New data show that at 12 months newly diagnosed patients taking Tasigna to treat a life-threatening form of chronic myeloid leukemia had rapid responses and a deep reduction in the amount of the abnormal protein that causes this disease.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09
Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09
Article Search
Sponsor